Prof Roberto Berni Canani, MD, PhD is an expert in Pediatrics at Federico II University Hospital (Italy). As of October 2026, ScienceLeadR ranks Roberto Berni Canani in the top 1% of experts worldwide for Food Hypersensitivity. Roberto Berni Canani has authored 307 publications, the most recent in 2026, and is an investigator in 48 clinical trials, 6 of them ongoing. SLR score: 1,847 (community average: 125). How the SLR is computed.

LeadR Profile

Prof Roberto Berni Canani, MD, PhD Federico II University Hospital Italy
1 847 ScienceLeadR Reputation 1847
Network Map

Pediatrics

Subspecialties: Nutrition - Immunology - Gastroenterology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1995 - 2026

Source: PubMed

University of Naples Federico II

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 307

Citations

Citations: 23 752 1st author: 64 Last author: 113 Unique author: 2


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Obesity, asthma, and allergy triangle: The solution could be the diet.
PMID 42562282 — quality of life, hypersensitivity, diet, solutions, immunity, obesity, asthma, allergy
Ann Allergy Asthma Immunol20260
Breast Milk and Allergic Disease Development: Immunological Factors Associated with Eczema, Food Allergy and Wheezing/Asthma.
PMID 42955504 — milk, human, milk, food hypersensitivity, hypersensitivity, immunologic factors, fatty acids, volatile, eczema, food, immunoglobulin a, secretory, breast, asthma, infant, fatty acids, allergy
Curr Allergy Asthma Rep20260
ACTN3 Variants Beyond Performance: Metabolic and Inflammatory Implications.
PMID 42938396 — genes, genomics, genetic predisposition to disease, athletic performance, genotype, athletes
Genes (Basel)20260
EAACI Spring Meeting 2026: Prevention as Treatment-A New Paradigm.
PMID 42671145 — hypersensitivity, therapeutics, education, medical, undergraduate
Allergy20260
Postbiotics Against Breast Cancer: A Narrative Review Bridging Preclinical Evidence with Potential Clinical Application.
PMID 42588703 — cells, breast neoplasms, neoplasms, neoplasm metastasis, breast, probiotics, therapeutics, microbiota
Cancers (Basel)20261

Clinical Studies 48

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 10 Study Director: 1

By phase:

N/A 39
Phase 2 4
Phase 2/Phase 3 2
Phase 3 2
Phase 4 1

By status:

Completed 33
Unknown 8
Recruiting 7

By type:

Interventional 29
Observational 19

By Monocentric/Multicentric:

monocentric 39
multicentric2to4 5
multicentric5to9 0
multicentricup10 4

Main Topics

Ongoing Clinical Trials

6 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Study to evaluate the effectiveness safety and quality of life of Bilaxten an allergy medication in children
2024-519550-36-00 — quality of life, safety, hypersensitivity, signs and symptoms, pruritus, child, allergy
Phase 4Recruiting2026
Evaluation of the Tolerance of a New Formula Based on Hydrolyzed Rice Proteins in Children With Cow s Milk Allergy
NCT07197814 — milk, milk hypersensitivity, hypersensitivity, milk proteins, infant formula, diet, food, child, infant, allergy
N/ARecruiting2026
The Role of NIchel and LTPs Sensitization in Functional Gastrointestinal Disorders the NILT Study
NCT07105865 — food hypersensitivity, dermatitis, lymphocytes, pain, hypersensitivity, nuts, allergens, food, signs and symptoms, prevalence, dyspepsia, gastrointestinal diseases, gastroesophageal reflux, abdominal pain, dermatitis, allergic contact, child, dermatitis, contact, allergy
N/ARecruiting2025
Effect of a Hydrolyzed Rice Protein based Formula on Growth Tolerance and Health related Quality of Life in Infants With Cow s Milk Protein Allergy
NCT06633250 — quality of life, milk, milk hypersensitivity, growth, hypersensitivity, milk proteins, infant, allergy
N/ARecruiting2024
Butyrate Supplementation in Children With Autism Spectrum Disorder (ASD) and Functional Gastrointestinal Disorders
NCT06514573 — butyric acid, butyrates, signs and symptoms, digestive, autism spectrum disorder, fatty acids, volatile, developmental disabilities, child development, autistic disorder, child development disorders, pervasive, signs and symptoms, behavioral symptoms, gastrointestinal diseases, gastrointestinal microbiome, microbiota, child, fatty acids
N/ARecruiting2025

LeadR Networks

Main global connection map